Dominik Schumacher, Tubulis CEO

Ger­man ADC biotech Tubu­lis rais­es $138M to en­ter the clin­ic and ex­pand in US

Mu­nich-based Tubu­lis has brought in promi­nent Eu­ro­pean and US in­vestors to back its work in an­ti­body-drug con­ju­gates, which have tak­en on­col­o­gy R&D by

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.